Regulated Information - Transparency Statement
Philippe Baron Vlerick confirms 3.6% shareholding in ThromboGenics nv
Leuven, Belgium, 19 May 2015 - Pursuant to Belgian transparency legislation (Law of 2 May 2007), ThromboGenics NV (Euronext Brussels: THR) received a transparency notification on 18 May 2015 from Philippe Baron Vlerick and controlled entities.
Mr. Vlerick notified that on 14 May 2015, a total of 1,299,732 shares representing 3.6% of the current 36.094.349 outstanding ThromboGenics shares were held by himself and through controlled entities.
distributed by |